Drug intelligence / Profile preview

clobetasol

Development stage
Approved
Lead developer
Formosa Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Clobetasol is a super-high-potency topical corticosteroid used to treat various inflammatory and pruritic skin conditions, including moderate to severe plaque psoriasis, eczema, atopic dermatitis, lichen planus, lichen sclerosus, cutaneous T-cell lymphoma (mycosis fungoides), and other corticosteroid-responsive dermatoses. It works by binding to the glucocorticoid receptor in skin cells, leading to decreased vasodilation and capillary permeability as well as reduced leukocyte migration. This results in potent anti-inflammatory and immunosuppressive effects. The drug also inhibits phospholipase A2 activity (reducing arachidonic acid derivatives) and suppresses pro-inflammatory gene expression while promoting anti-inflammatory genes such as interleukin 10[6][8]. It is available in multiple topical formulations (cream, ointment, gel/jelly, foam, lotion, shampoo) for application on the skin or scalp[5]. Developed decades ago as a synthetic corticosteroid derivative.

Brand names
TemovateClobexDermovateOluxImpoyzCormaxClareluxClobaDermEtrivexClodanEmbelineImpekloTovetTenovateDermatovateButavateMovateNovateSalacPowercortLotasbatKloderma
Other names
clobetasol propionate
02

Targets

MR (Mineralocorticoid receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on clobetasol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call